0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Case Report/Case Series |

Locoregional Multiple Nodular Panniculitis Induced by Pseudomonas aeruginosa Without Septicemia Three Cases and Focus on Predisposing Factors FREE

Mélanie Roriz, MD1; Annabel Maruani, MD, PhD1,2; Emmanuelle Le Bidre, MD1; Marie-Christine Machet, MD3; Laurent Machet, MD, PhD1,2; Mahtab Samimi, MD1,4
[+] Author Affiliations
1Department of Dermatology, University François Rabelais, Hospital of Tours, Tours, France
2INSERM U930, University François Rabelais, Tours, France
3Department of Pathology, University François Rabelais, Hospital of Tours, Tours, France
4Laboratory of Molecular Virology and Immunology, ISP 1282, INRA-University François Rabelais, Tours, France
JAMA Dermatol. 2014;150(6):628-632. doi:10.1001/jamadermatol.2013.9340.
Text Size: A A A
Published online

ABSTRACT

Importance  Pseudomonas aeruginosa–induced locoregional multiple nodular panniculitis without septicemia is an underreported condition, with only 3 cases reported to date. We report 3 new cases of P aeruginosa–induced multiple nodular panniculitis without septicemia and describe common features among all 6 cases, thus providing the first description, to our knowledge, of the natural history and potential predisposing factors for this entity.

Observations  Median age of the 6 patients was 74 years (range, 54-84 years). Patients had inflammatory nodules on a lower limb (n = 6) that were unilateral (n = 6) and had no fever (n = 5). Blood cultures were negative (n = 5). Skin biopsy specimens revealed panniculitis (n = 5), with skin cultures positive for P aeruginosa (n = 6). Skin nodules resolved with systemic antibiotics (n = 5). The comorbidities recorded were type 1 or 2 diabetes mellitus (n = 5), overweight (n = 3), and combined locoregional anatomical changes in the lower limbs (n = 5). Local skin injury, which constituted the portal entry, was present in all cases, especially leg ulcers (n = 3).

Conclusions and Relevance  We describe P aeruginosa–induced locoregional nodular panniculitis as a distinct entity. This should be investigated in elderly, diabetic, overweight patients with inflammatory nodules on a lower limb associated with locoregional anatomical changes and skin injury, with the optimal antibiotic regimen introduced as rapidly as possible.

Figures in this Article

Skin manifestations caused by Pseudomonas aeruginosa are classified as primary or secondary cutaneous lesions.14 Primary cutaneous lesions (eg, pyoderma, intertrigo, and folliculitis) arise in previously healthy patients with predisposing factors such as maceration and skin damage, whereas secondary cutaneous lesions usually occur in immunosuppressed patients by blood dissemination of P aeruginosa in a context of bacteremia or septicemia. Such secondary cutaneous lesions include ecthyma gangrenosum, hemorrhagic vesicles and blisters, cellulitis, fasciitis, gangrene, and panniculitis.1 Indeed, multiple nodular panniculitis classically constitutes a secondary cutaneous manifestation of P aeruginosa in a context of septicemia in immunosuppressed patients.24 On the other hand, P aeruginosa–induced locoregional multiple nodular panniculitis without septicemia seems rare, and to our knowledge, only 3 cases have been reported.57 The natural history and predisposing factors of this condition, therefore, have not been assessed. We report 3 new cases of P aeruginosa–induced multiple nodular panniculitis without septicemia and describe common features in the 6 cases, thus constituting the first description, to our knowledge, of the natural history and potential predisposing factors of this probably underdiagnosed entity.

REPORT OF CASES

Patient 1

A woman in her 80s was admitted for chronic leg ulcers related to venous insufficiency and chronic limb lymphedema. Her medical history included type 1 diabetes mellitus, chronic renal failure, and atrial fibrillation. She was treated with insulin, acetylsalicylic acid, fluindione, ramipril, atorvastatin, and bisoprolol hemifumarate. On admission, she had multiple ulcers on the right lateral malleolus and macerated interdigital intertrigo of both feet. She also had inflammatory nodules on the left thigh that had appeared 6 days before with no systemic symptoms (Figure 1A). Relevant clinical and paraclinical findings are reported in Table 1 and Table 2. In particular, there was no bacteremia or evidence of underlying immunosuppression. A skin biopsy specimen of a nodule showed neutrophilic panniculitis and no vasculitis (Figure 2A), and multisensitive P aeruginosa was isolated from a skin biopsy sample. Pseudomonas aeruginosa with the same antibiogram profile had been isolated from the ulcer on her contralateral limb 1 month earlier. No bacteriologic sampling of the interdigital intertrigo was performed. The nodules resolved rapidly after treatment with ciprofloxacin hydrochloride for 14 days.

Place holder to copy figure label and caption
Figure 1.
Clinical Presentation

Multiple erythematous subcutaneous nodules on the left thigh in patient 1 (A) and on the right thigh in patient 3 (B).

Graphic Jump Location
Table Graphic Jump LocationTable 1.  Systemic and Local Conditions in the Reported Cases of Pseudomonas aeruginosa–Induced Locoregional Multiple Nodular Panniculitis
Table Graphic Jump LocationTable 2.  Clinical and Paraclinical Outcomes of Pseudomonas aeruginosa Infection in the Reported Casesa
Place holder to copy figure label and caption
Figure 2.
Histologic Findings After Biopsy of Inflammatory Nodules

A, Acute inflammatory lobular panniculitis with intense neutrophilic infiltrate and no vasculitis (patient 1) (hematein phloxin safran, original magnification ×20). B, Lobular and septal panniculitis with intense neutrophilic infiltrate and no vasculitis (patient 2) (hematein phloxin safran, original magnification ×10). C, Septal and lobular panniculitis with intense neutrophilic infiltrate (patient 3) (hematein phloxin safran, original magnification ×20).

Graphic Jump Location
Patient 2

A man in his 50s was referred for infiltrated and necrotic purpuric lesions of the legs that had appeared 10 days previously with progressive extension to the trunk. He had a medical history of obesity, type 1 diabetes mellitus, and dilated heart disease. His treatment consisted of insulin, furosemide, fluindione, bisoprolol, perindopril arginine, atorvastatin, and digoxin. Sildenafil citrate had been introduced 12 days before for pulmonary hypertension related to his heart condition. Clinical and histologic findings were consistent with leukocytoclastic cutaneous vasculitis (LCV). A systemic involvement was ruled out by clinical examination, laboratory tests (C-reactive protein, 10 mg/L [to convert to nanomoles per liter, multiply by 9.524]; complete blood count; and renal and liver function tests), and imaging (chest radiography and echocardiography). There was no evidence of an infectious process accounting for the LCV. Investigations (protein and immunoglobulin electrophoresis, autoimmune antibodies, cryoglobulinemia, and hepatitis B virus, hepatitis C virus, and human immunodeficiency virus serology) were unremarkable. Sildenafil was suspected and withdrawn. There was progressive resolution of the LCV with topical corticosteroids and colchicine. One month later, the patient developed inflammatory nodules on his left leg, where there remained some infracentimetric cutaneous ulcers secondary to the necrotic purpura. Relevant clinical and paraclinical findings are reported in Table 1 and Table 2. A skin biopsy specimen showed neutrophilic panniculitis (Figure 2B), and skin culture was positive for multisensitive P aeruginosa. The nodules rapidly resolved after treatment with ciprofloxacin for 15 days. He had no other flare-up of vasculitis during the following 6 months with colchicine.

Patient 3

A woman in her 70s was referred for a venous ulcer on the right leg lasting for 2 months. Her medical history included hypertrophic cardiomyopathy and high blood pressure. Her long-term treatment included atenolol. Six days after admission, she developed inflammatory nodules on the right limb (Figure 1B) with no systemic symptoms. Relevant clinical and paraclinical findings are reported in Table 1 and Table 2. Amoxicillin trihydrate–potassium clavulanic, 3 g/d, was introduced for the panniculitis after systematic blood cultures. Her condition rapidly worsened with confusion and ascites. Laboratory investigations revealed deterioration of hepatic function (prothrombin index, 35%; factor V, 47%; aspartate aminotransferase, 94 U/L [normal, <45]; alanine aminotransferase, 211 U/L [normal, <35]; total bilirubin, 2.16 mg/dL [normal, <25]; serum ammonia, 79.83 μg/dL [normal, <50]; and serum albumin, 2.4 g/dL) that led to the diagnosis of a chronic active hepatitis B virus infection (hepatitis B core antibody IgG positive, hepatitis B core antibody IgM negative, hepatitis B surface antigen positive, and hepatitis B virus DNA, 7 log copies/mL) (to convert aspartate aminotransferase and alanine aminotransferase to microkatals per liter, multiply by 0.01667 and 0.0167, respectively; total bilirubin and serum ammonia to micromoles per liter, multiply by 17.104 and 0.714, respectively; and serum albumin to grams per liter, multiply by 10). Results of abdominal ultrasonography were consistent with liver cirrhosis. Further bacteriologic sampling (cerebrospinal fluid, ascites, and blood cultures), performed during amoxicillin–clavulanic treatment, was negative. A biopsy specimen of a cutaneous nodule showed neutrophilic panniculitis and no vasculitis (Figure 2C), and culture was positive for multiresistant P aeruginosa. Ceftazidime pentahydrate and amikacin sulfate were started and the nodules had resolved when she died of grade IV hepatic encephalopathy 15 days later.

DISCUSSION

Nodular panniculitis due to P aeruginosaclassically constitutes manifestation of blood dissemination of the bacteria during septicemia in immunosuppressed patients.24 We report 3 cases of P aeruginosa–induced locoregional panniculitis with no septicemia and discovered only 3 such cases reported in the literature,57 making it probably an underdiagnosed and/or underreported condition. Interestingly, we found striking similarities among the previously reported cases and our 3 cases, allowing for a description of the natural history and the predisposing factors for this entity.

The clinical and paraclinical outcomes of the P aeruginosa infection in these 6 cases are summarized in Table 2. Multiple inflammatory nodules had developed out of the hospital (n = 3) or during hospitalization (n = 3). There was no fever or systemic signs (n = 5) or only a transient fever with no systemic signs (n = 1). Nodules were located unilaterally on a lower limb (n = 6). There was a high level of inflammatory syndrome (median C-reactive protein, 168 mg/L; range, 21-301 mg/L). Blood cultures were negative (n = 5) or had not been performed because of the absence of fever with a minor inflammatory syndrome (n = 1). There was no evidence of endocarditis on echocardiography (n = 5). Skin or pus cultures were positive for P aeruginosa (n = 6), most with a multisensitive profile (n = 4). Biopsy specimens revealed neutrophilic lobular (n = 3) or septal and lobular (n = 2) panniculitis, with extension to the deep dermis. In one patient, clinical features were consistent with panniculitis, whereas histopathologic findings and magnetic resonance imaging revealed abscesses.6 It remains unclear whether this patient had pseudomonal abscesses rather than panniculitis.

The anatomoclinical features of our cases distinguished them from ecthyma gangrenosum, another secondary cutaneous manifestation of P aeruginosa that has also been described with no septicemia,8 including in immunocompetent patients.9 There has been some controversy whether ecthyma gangrenosum without bacteremia represents a manifestation of initially undetectable bacteremia or a primary cutaneous infection.8 Our case series showed no evidence that panniculitis indicated initially undetectable bacteremia, based on the absence of systemic signs and the negativity of blood cultures drawn before administration of antibiotics.

Regarding the prognosis of the infectious process, skin nodules resolved under systemic antibiotics (n = 5) or with an additional surgical incision (n = 1), and no patients developed septicemia. All patients had been treated within 7 days after the onset of panniculitis, and it is unclear whether they would have developed septicemia without prompt therapy. We did not find any reports in the literature in which P aeruginosa–induced locoregional panniculitis turned into septicemia.

The overall prognosis of such panniculitis is more debatable. Pseudomonas aeruginosa bacteremia, irrespective of the cutaneous findings, is associated with mortality rates up to 39%.10 Patients developing ecthyma gangrenosum with no septicemia had a better prognosis than those with septicemia.8 Similarly, 1 death from septicemia was reported in the 17 previous cases of P aeruginosa panniculitis with septicemia,3 whereas none occurred in our case series. However, the patients in our series were older and had more comorbidities, and the outcome was fatal for 2, despite the absence of septicemia. These 2 patients developed the nodules in the hospital, with the intermediate-sensitive P aeruginosa possibly being acquired there. It is possible that the infectious process worsened organ failure; therefore, early diagnosis and treatment of such panniculitis should be recommended, especially in debilitated patients.

The predisposing factors for all reported cases of P aeruginosa–induced locoregional panniculitis are reported in Table 1. Median age was 74 years (range, 54-84 years). Frequent comorbidities were type 1 or 2 diabetes mellitus (n = 5), for which 4 patients received insulin therapy, and chronic heart disease (n = 5). Type 1 and 2 diabetes mellitus may represent a predisposing factor due to immunity impairment, although it was well controlled in 3 patients. Heart disease is usually not associated with a heightened risk of skin infections, although one study reported an increase in wound infections in patients receiving antihypertensives.11 The high prevalence of chronic heart disease in this series may also be related to the high median age. Body mass index, when available (n = 4), indicated that most patients were overweight (n = 3), which is also related to an increased risk of infection.12 Interestingly, most patients had combined locoregional anatomical changes in the lower limbs (venous insufficiency, n = 3; arterial insufficiency, n = 2; lymphedema, n = 1; and lipoedema, n = 1), consistent with risk factors previously described for limb erysipelas.12 Similarly, a local skin injury was reported in all patients (homolateral leg ulcer, n = 3; ulcers secondary to LCV, n = 1; interdigital intertrigo, n = 1; and traumatic injury, n = 1). Pseudomonas aeruginosa with the same antibiogram profile had been isolated from cutaneous ulcers (n = 3), suggesting that long-term wound colonization may have favored skin infection. No bacteriologic results were available for the other 3 cases to confirm homolateral skin injury as the primary site of P aeruginosa infection. Although P aeruginosa has been isolated in 30% to 40% of leg ulcers,13 only some seem to develop panniculitis, suggesting that other predisposing factors are necessary for P aeruginosa–induced panniculitis. Insulin injections (n = 4) also may have constituted a breach of the cutaneous barrier and favored bacterial penetration, but the nodules were not located at the sites of insulin injections.

Unlike patients who develop panniculitis in the context of septicemia, those with P aeruginosa–induced locoregional panniculitis seem to have a relatively preserved immune condition. None of these patients had received systemic immunosuppressive therapy, but 1 patient had applied clobetasol for LCV for 1 month, which could have favored local infection. Immunity status had been investigated by γ-globulin count (n = 3), IgG count (n = 4), and human immunodeficiency virus serology (n = 4), but the results were unremarkable. Interestingly, total lymphocyte count was mostly decreased (n = 3) when performed (n = 4), with no further information on the lymphocyte subset analysis. When performed (n = 4), the serum albumin count was also mostly decreased (n = 3), possibly indicative of impaired nutritional status or related to the inflammatory syndrome.

The physiopathologic mechanism for such P aeruginosa–induced nodular panniculitis without bacteremia has to be distinguished from secondary skin lesions due to blood dissemination of P aeruginosa.1,14 In our cases, unilateral, locoregionally distributed, multiple nodules upstream from a skin injury are consistent with lymphatic dissemination of the bacterium from a primary infectious site. Other organisms involved in locoregional panniculitis include bacteria (Streptococcus species, Staphylococcus aureus, and Mycobacterium species), fungi, and parasites,15 which may similarly spread from the inoculated source in a sporotrichoid pattern. However, bacterial panniculitis manifests as suppurative panniculitis, whereas granulomatous patterns are mostly reported with Mycobacterium species, fungi, and parasites.15

The overall systemic immunocompetent status of the 6 reported cases could explain the locoregional limitation of the infectious process. The general systemic predisposing factors appear to be advanced age, type 1 or 2 diabetes mellitus, chronic heart disease, and overweight. Local predisposing factors are anatomical changes, such as venous, arterial, or lymphatic insufficiency, and local skin injury, especially leg ulcers with P aeruginosa colonization.

CONCLUSIONS

Pseudomonas aeruginosa–induced nodular panniculitis is probably an underrecognized condition. It should be suspected in an elderly, diabetic, overweight patient with unilateral inflammatory nodules on a lower limb, even in the absence of fever, systemic symptoms, or immunosuppressive condition, and especially when combined with locoregional anatomical changes and concomitant skin injury, so that an optimal antibiotic regimen can be introduced as rapidly as possible.

ARTICLE INFORMATION

Accepted for Publication: October 28, 2013.

Corresponding Author: Mahtab Samimi, MD, Department of Dermatology, Laboratory of Molecular Virology and Immunology, ISP 1282, INRA-University François Rabelais, Hospital of Tours, Tours, France (samimi.mahtab@yahoo.fr).

Published Online: March 26, 2014. doi:10.1001/jamadermatol.2013.9340.

Author Contributions: Drs Roriz and Samimi had access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Study concept and design: Roriz, Maruani, Samimi.

Acquisition of data: Roriz, Maruani, Le Bidre, M.-C. Machet, Samimi.

Analysis and interpretation of data: Maruani, L. Machet, Samimi.

Drafting of the manuscript: Roriz, M.-C. Machet, Samimi.

Critical revision of the manuscript for important intellectual content: Maruani, Le Bidre, L. Machet, Samimi.

Administrative, technical, or material support: M.-C. Machet.

Study supervision: Maruani, L. Machet, Samimi.

Conflict of Interest Disclosures: None reported.

REFERENCES

Silvestre  JF, Betlloch  MI.  Cutaneous manifestations due to Pseudomonas infection. Int J Dermatol. 1999;38(6):419-431.
PubMed   |  Link to Article
Schlossberg  D.  Multiple erythematous nodules as a manifestation of Pseudomonas aeruginosa septicemia. Arch Dermatol. 1980;116(4):446-447.
PubMed   |  Link to Article
Fleming  MG, Milburn  PB, Prose  NS.  Pseudomonas septicemia with nodules and bullae. Pediatr Dermatol. 1987;4(1):18-20.
PubMed   |  Link to Article
Tariq  S, Hameed  S, Tyrer  M, Johnson  M, Lipman  M.  Pseudomonal sepsis with subcutaneous nodules in an HIV-infected individual with high CD4 counts. J Infect. 2005;51(5):419-420.
PubMed   |  Link to Article
Aleman  CT, Wallace  ML, Blaylock  WK, Garrett  AB.  Subcutaneous nodules caused by Pseudomonas aeruginosa without sepsis. Cutis. 1999;63(3):161-163.
PubMed
Picard  D, de Quatrebarbes  J, Gueit  I, Joly  P.  Atypical nodular panniculitis. Int J Infect Dis. 2011;15(4):e289-e290.
PubMed   |  Link to Article
Penz  S, Puzenat  E, Saccomani  C,  et al.  Locoregional polymorphous Pseudomonas aeruginosa skin infection [in French]. Med Mal Infect. 2010;40(10):593-595.
PubMed   |  Link to Article
Huminer  D, Siegman-Igra  Y, Morduchowicz  G, Pitlik  SD.  Ecthyma gangrenosum without bacteremia: report of six cases and review of the literature. Arch Intern Med. 1987;147(2):299-301.
PubMed   |  Link to Article
Gençer  S, Ozer  S, Ege Gül  A, Doğan  M, Ak  O.  Ecthyma gangrenosum without bacteremia in a previously healthy man: a case report. J Med Case Rep. 2008;2:14.
PubMed   |  Link to Article
Kang  CI, Kim  SH, Kim  HB,  et al.  Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis. 2003;37(6):745-751.
PubMed   |  Link to Article
Penington  A.  Ulceration and antihypertensive use are risk factors for infection after skin lesion excision. ANZ J Surg. 2010;80(9):642-645.
PubMed   |  Link to Article
Dupuy  A, Benchikhi  H, Roujeau  JC,  et al.  Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ. 1999;318(7198):1591-1594.
PubMed   |  Link to Article
Lim  T, Mwipatayi  B, Murray  R, Sieunarine  K, Abbas  M, Angel  D.  Microbiological profile of chronic ulcers of the lower limb: a prospective observational cohort study. ANZ J Surg. 2006;76(8):688-692.
PubMed   |  Link to Article
el Baze  P, Thyss  A, Vinti  H, Deville  A, Dellamonica  P, Ortonne  JP.  A study of nineteen immunocompromised patients with extensive skin lesions caused by Pseudomonas aeruginosa with and without bacteremia. Acta Derm Venereol. 1991;71(5):411-415.
PubMed
Morrison  LK, Rapini  R, Willison  CB, Tyring  S.  Infection and panniculitis. Dermatol Ther. 2010;23(4):328-340.
PubMed   |  Link to Article

Figures

Place holder to copy figure label and caption
Figure 1.
Clinical Presentation

Multiple erythematous subcutaneous nodules on the left thigh in patient 1 (A) and on the right thigh in patient 3 (B).

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.
Histologic Findings After Biopsy of Inflammatory Nodules

A, Acute inflammatory lobular panniculitis with intense neutrophilic infiltrate and no vasculitis (patient 1) (hematein phloxin safran, original magnification ×20). B, Lobular and septal panniculitis with intense neutrophilic infiltrate and no vasculitis (patient 2) (hematein phloxin safran, original magnification ×10). C, Septal and lobular panniculitis with intense neutrophilic infiltrate (patient 3) (hematein phloxin safran, original magnification ×20).

Graphic Jump Location

Tables

Table Graphic Jump LocationTable 1.  Systemic and Local Conditions in the Reported Cases of Pseudomonas aeruginosa–Induced Locoregional Multiple Nodular Panniculitis
Table Graphic Jump LocationTable 2.  Clinical and Paraclinical Outcomes of Pseudomonas aeruginosa Infection in the Reported Casesa

References

Silvestre  JF, Betlloch  MI.  Cutaneous manifestations due to Pseudomonas infection. Int J Dermatol. 1999;38(6):419-431.
PubMed   |  Link to Article
Schlossberg  D.  Multiple erythematous nodules as a manifestation of Pseudomonas aeruginosa septicemia. Arch Dermatol. 1980;116(4):446-447.
PubMed   |  Link to Article
Fleming  MG, Milburn  PB, Prose  NS.  Pseudomonas septicemia with nodules and bullae. Pediatr Dermatol. 1987;4(1):18-20.
PubMed   |  Link to Article
Tariq  S, Hameed  S, Tyrer  M, Johnson  M, Lipman  M.  Pseudomonal sepsis with subcutaneous nodules in an HIV-infected individual with high CD4 counts. J Infect. 2005;51(5):419-420.
PubMed   |  Link to Article
Aleman  CT, Wallace  ML, Blaylock  WK, Garrett  AB.  Subcutaneous nodules caused by Pseudomonas aeruginosa without sepsis. Cutis. 1999;63(3):161-163.
PubMed
Picard  D, de Quatrebarbes  J, Gueit  I, Joly  P.  Atypical nodular panniculitis. Int J Infect Dis. 2011;15(4):e289-e290.
PubMed   |  Link to Article
Penz  S, Puzenat  E, Saccomani  C,  et al.  Locoregional polymorphous Pseudomonas aeruginosa skin infection [in French]. Med Mal Infect. 2010;40(10):593-595.
PubMed   |  Link to Article
Huminer  D, Siegman-Igra  Y, Morduchowicz  G, Pitlik  SD.  Ecthyma gangrenosum without bacteremia: report of six cases and review of the literature. Arch Intern Med. 1987;147(2):299-301.
PubMed   |  Link to Article
Gençer  S, Ozer  S, Ege Gül  A, Doğan  M, Ak  O.  Ecthyma gangrenosum without bacteremia in a previously healthy man: a case report. J Med Case Rep. 2008;2:14.
PubMed   |  Link to Article
Kang  CI, Kim  SH, Kim  HB,  et al.  Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis. 2003;37(6):745-751.
PubMed   |  Link to Article
Penington  A.  Ulceration and antihypertensive use are risk factors for infection after skin lesion excision. ANZ J Surg. 2010;80(9):642-645.
PubMed   |  Link to Article
Dupuy  A, Benchikhi  H, Roujeau  JC,  et al.  Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ. 1999;318(7198):1591-1594.
PubMed   |  Link to Article
Lim  T, Mwipatayi  B, Murray  R, Sieunarine  K, Abbas  M, Angel  D.  Microbiological profile of chronic ulcers of the lower limb: a prospective observational cohort study. ANZ J Surg. 2006;76(8):688-692.
PubMed   |  Link to Article
el Baze  P, Thyss  A, Vinti  H, Deville  A, Dellamonica  P, Ortonne  JP.  A study of nineteen immunocompromised patients with extensive skin lesions caused by Pseudomonas aeruginosa with and without bacteremia. Acta Derm Venereol. 1991;71(5):411-415.
PubMed
Morrison  LK, Rapini  R, Willison  CB, Tyring  S.  Infection and panniculitis. Dermatol Ther. 2010;23(4):328-340.
PubMed   |  Link to Article

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment
Locoregional panniculitis induced by Pseudomonas aeruginosa without septicemia: an under-diagnosed entity
Posted on June 8, 2014
Mahtab Samimi (1) ; Mathilde Barbaz (2)
(1) Dermatology and (2) Intensive Care Unit Departments, University François Rabelais, Hospital of Tours, France
Conflict of Interest: None Declared
Dear Editor,We recently reported a series of 3 patients with Pseudomonas aeruginosa (P. aeruginosa) - induced locoregional nodular panniculitis, with no septicemia (1). We had found only 3 previous cases in the literature (2-4), and suggested that this entity was under-diagnosed and/or under-reported. In fact, we have recently had another case. Interestingly, this patient was immunocompromised, but the clinical presentation was similar to those we had previously reported. This 66-year-old woman was in the intensive care unit after liver transplantation for alcoholic Child C cirrhosis. Her medical history included hypertension, dyslipidemia and psoriasis. On admission, cutaneous examination found bilateral limb edema and a superficial wound on the right thigh. Systematic blood cultures after transplantation and of intra-operative patient and donor samples were negative. At day 5 after transplantation, while being treated with mycophenolate mofetil, tacrolimus and methylprednisolone, she had a transient fever (38°C) with dermohypodermitis of her right lower limb. Blood cultures were negative. Urinary catheter samples revealed moderate leucocyturia (330/mm3) and 106 bacteria/mL (P. aeruginosa, ticarcillin-sensitive, piperacillin/tazobactam-sensitive, ceftazidime-resistant). Amoxicillin-clavulanic acid (3g/day) was started. At day 7, she was still apyretic but the erythema worsened, with pustules positive for P. aeruginosa with the same antibiogram. Piperacillin/tazobactam (16g/day) and clindamycin (1800mg/day) were started intravenously with favorable local outcome. However, at day 12, she developed multiple nodular panniculitis on her thigh (Fig. 1), with skin biopsy culture positive for P. aeruginosa with the same antibiogram. No histology was performed. Blood cultures remained negative. Clinical evolution was favorable within 10 days with the same antibiotics.This patient had a similar clinical presentation to those we had previously reported, i.e. P.aeruginosa-induced nodular panniculitis unilaterally distributed on a lower limb, with no septicemia. Moreover, the locoregional risk factors were consistent with our previous reports: bilateral limb edema, homolateral skin injury. Despite considerate impairment of her immune condition, the infectious event remained localized and evolved favorably with the appropriate antibiotics. Detection of P.aeruginosa in the urinary catheter with moderate leucocyturia suggested cutaneous contamination from the perineum, rather than undetected blood dissemination. Contamination from the perineum may have led to the dermohypodermitis, the entry portal being the contiguous skin injury of the thigh, followed by lymphatic spread along the homolateral limb. Overall, we are convinced that P. aeruginosa - induced locoregional nodular panniculitis is more frequent than currently believed and should be evoked when a patient has unilateral nodular panniculitis on a lower limb.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

1,048 Views
1 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
Jobs